| Issue Date | Title | Author(s) |
| 2022-08 | Application of circulating tumour cells to predict response to treatment in head and neck cancer. | Zhang, X; Ekanayake Weeramange, C; Hughes, BGM; Vasani, S; Liu, ZY; Warkiani, ME; Hartel, G; Ladwa, R; Thiery, JP; Kenny, L; Punyadeera, C |
| 2024 | Characterisation of circulating tumor-associated and immune cells in patients with advanced-stage non-small cell lung cancer. | Yaghoubi Naei, V; Ivanova, E; Mullally, W; O'Leary, CG; Ladwa, R; O'Byrne, K; Warkiani, ME; Kulasinghe, A |
| 2024-05-23 | Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients. | Zhang, X; Weeramange, CE; Hughes, BGM; Vasani, S; Liu, ZY; Warkiani, M; Hartel, G; Ladwa, R; Thiery, JP; Kenny, L; Breik, O; Punyadeera, C |
| 2022 | Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update. | Kapeleris, J; Ebrahimi Warkiani, M; Kulasinghe, A; Vela, I; Kenny, L; Ladwa, R; O'Byrne, K; Punyadeera, C |
| 2023 | Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. | Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A |
| 2020-11-27 | High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). | Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2022-07 | Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. | Kapeleris, J; Müller Bark, J; Ranjit, S; Irwin, D; Hartel, G; Warkiani, ME; Leo, P; O'Leary, C; Ladwa, R; O'Byrne, K; Hughes, BGM; Punyadeera, C |
| 2024-07-24 | Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response. | Sadeghirad, H; Monkman, J; Tan, CW; Liu, N; Yunis, J; Donovan, ML; Moradi, A; Jhaveri, N; Perry, C; Adams, MN; O'Byrne, K; Warkiani, ME; Ladwa, R; Hughes, BGM; Kulasinghe, A |
| 2022-05-16 | Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial). | Ladwa, R; Pinkham, EP; Teleni, L; Hanley, B; Lock, G; Nixon, J; Agbejule, OA; Crawford-Williams, F; Jones, L; Pinkham, MB; Turner, J; Yates, P; McPhail, SM; Aitken, JF; Escalante, CP; Hart, NH; Chan, RJ |
| 2021 | The Role of Circulating Biomarkers in Lung Cancer. | Herath, S; Sadeghi Rad, H; Radfar, P; Ladwa, R; Warkiani, M; O'Byrne, K; Kulasinghe, A |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
| 2022 | Understanding the tumor microenvironment in head and neck squamous cell carcinoma. | Rad, HS; Shiravand, Y; Radfar, P; Ladwa, R; Perry, C; Han, X; Warkiani, ME; Adams, MN; Hughes, BG; O'Byrne, K; Kulasinghe, A |
